AllianceBernstein’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $359K | Sell |
47,630
-1,675,371
| -97% | -$12.6M | ﹤0.01% | 2826 |
|
|
2025
Q1 | $13M | Sell |
1,723,001
-288,524
| -14% | -$2.18M | ﹤0.01% | 1036 |
|
|
2024
Q4 | $24.5M | Buy |
2,011,525
+157,115
| +8% | +$1.91M | 0.01% | 839 |
|
|
2024
Q3 | $31M | Buy |
1,854,410
+125,865
| +7% | +$2.11M | 0.01% | 759 |
|
|
2024
Q2 | $30.1M | Buy |
1,728,545
+1,695,345
| +5,106% | +$29.6M | 0.01% | 755 |
|
|
2024
Q1 | $566K | Sell |
33,200
-10,180
| -23% | -$173K | ﹤0.01% | 2531 |
|
|
2023
Q4 | $442K | Sell |
43,380
-360
| -0.8% | -$3.67K | ﹤0.01% | 2668 |
|
|
2023
Q3 | $396K | Hold |
43,740
| – | – | ﹤0.01% | 2683 |
|
|
2023
Q2 | $471K | Buy |
43,740
+11,040
| +34% | +$119K | ﹤0.01% | 2672 |
|
|
2023
Q1 | $335K | Buy |
32,700
+4,500
| +16% | +$46K | ﹤0.01% | 2734 |
|
|
2022
Q4 | $298K | Buy |
28,200
+1,500
| +6% | +$15.8K | ﹤0.01% | 2877 |
|
|
2022
Q3 | $342K | Buy |
26,700
+2,400
| +10% | +$30.7K | ﹤0.01% | 2804 |
|
|
2022
Q2 | $312K | Buy |
24,300
+10,200
| +72% | +$131K | ﹤0.01% | 2860 |
|
|
2022
Q1 | $148K | Sell |
14,100
-1,800
| -11% | -$18.9K | ﹤0.01% | 3044 |
|
|
2021
Q4 | $245K | Buy |
15,900
+2,100
| +15% | +$32.4K | ﹤0.01% | 2994 |
|
|
2021
Q3 | $311K | Hold |
13,800
| – | – | ﹤0.01% | 2931 |
|
|
2021
Q2 | $355K | Buy |
+13,800
| New | +$355K | ﹤0.01% | 2951 |
|